Axitinib for the Management of Metastatic Renal Cell Carcinoma
Drugs in R and D - United Kingdom
doi 10.2165/11591240-000000000-00000
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2011
Authors
Publisher
Springer Science and Business Media LLC